Where does Neuro Code Tech Holdings, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neuro Code Tech Holdings, LLC ranks #49,032 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neuro Code Tech Holdings, LLC hold?

Neuro Code Tech Holdings, LLC holds 5 US utility patents granted between 2016 and 2017, spanning 3 technology areas.

What is Neuro Code Tech Holdings, LLC's Innovation Score?

Neuro Code Tech Holdings, LLC has an Innovation Score of 22.4 out of 100 (10th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neuro Code Tech Holdings, LLC focus on?

Neuro Code Tech Holdings, LLC's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 5 patents, ranking #681 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Neuro Code Tech Holdings, LLC's patent grant rate increasing or decreasing?

Neuro Code Tech Holdings, LLC's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Neuro Code Tech Holdings, LLC's patents?

Neuro Code Tech Holdings, LLC's patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neuro Code Tech Holdings, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neuro Code Tech Holdings, LLC

USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2016–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neuro ranks #49,032 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.

#49,032
of 49,997 US assignees by volume: 10th percentile
by Innovation Score (22.4/100): 16.8
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49032 · US Corporation #49,032 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,032/49,997
PHOTO-FINISH Netduma Software
CPC-NARROW A61N · 3 areas
INNOV-THIN 22.4/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Netduma Software, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neuro’s 22.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (28%) Velocity 0.0 pts (0%) Breadth 6.1 pts (27%) Claim depth 10.1 pts (45%)

Qualcomm Incorporated · highest

85
Neuro Code Tech… · this assignee

22
3D Lighting… · lowest

7

What this shows Neuro's Innovation Score is 22.4/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neuro?

Each dot is one of Neuro’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuro’s own 16.8 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Neuro vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neuro's grants concentrate

Neuro Code Tech Holdings, LLC is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (3 grants) versus a trough of 2 in 2017. By volume, Neuro sits between Netduma Software, Ltd. and Neurophyxia B.V..

Netduma Software

5
Netra Systems

5
Neushield

5
Neural Propulsion…

5
Neurocardiac Inno…

5
Neurodon

5
Neurological Fitn…

5
Neurophyxia B V

5
Neuro Code Tech H… ◀

5

What this shows Neuro holds 5 patents at rank #49,145, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neuro

By rank, the assignees closest to #49,145 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Neuro's primary technology class.

Neuro's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

22 10th percentile higher than 10% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Neuro Code Tech Holdings, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	60.0%
2017	2	40.0%

Which technologies does Neuro Code Tech Holdings, LLC patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neuro Code Tech Holdings, LLC's patent record in context - here's where to go next.

Neuro Code Tech Holdings, LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #49,032 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neuro Code Tech Holdings, LLC against Netduma Software, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.